El Salvador reaches an agreement with Pfizer for 4.4 million COVID-19 vaccines

By Karla Ramos  |  Wednesday, May 5th, 2021
Pfizer COVID-19 Vaccine
Pfizer COVID-19 Vaccine

On Tuesday, May 4, Salvadoran president Nayib Bukele announced that the Government of El Salvador and Pfizer / BioNTech had signed an agreement for 4.4 million anti-COVID-19 vaccines.

“With this purchase, we guarantee uninterrupted immunization for our entire target population,” said President Bukele.

With this agreement to acquire 4.4 million vaccines from Pfizer/BioNTech, the country could meet its goal of immunizing 4.5 million Salvadorans in the short term.

President Bukele also announced the enabling of the house to house vaccination; this is an option available for the many people who, with all the options available, could not reach any of the vaccination centers.

Salvadorans who are eligible to get the COVID-19 vaccine have the option of one of the following locations, the 160 centers scatter all over the territory, the three auto vaccination centers, the Vaccination Megacenter at Hospital El Salvador, and now home vaccination.

Since February 17, when the immunization process began in the country, front-line health workers, people over 50, teachers, police, military, firefighters, Civil Protection personnel, and journalists have been vaccinated.

As of May 5, the largest batch of vaccines that the Salvadoran Government had acquired is from the Chinese pharmaceutical company Sinovac. A total of 1,650,000 doses, of which the People’s Republic of China donated 150,000, and the rest were purchased.

Additionally, El Salvador has received 149,600 AstraZeneca brand vaccines, 20,000 purchased, and the rest received as donations through the COVAX program.

The Government’s main objective is to vaccinate 4.5 million Salvadorans before the end of the year; therefore, the economy can fully reactivate next year. According to the government website and a tweet from President Bukele, El Salvador has vaccinated 1 million Salvadorans with its first dose.

The Latest NEWS